5-(2-FUryl)thieno[2,3-d]pyrimidin-4(3h)-one

Catalog No.: 
ACLUCW213
CAS No.: 
256507-00-3
Molecular Formula: 
C10H6N2O2S
Molecular Weight: 
218.24
5-(2-FUryl)thieno[2,3-d]pyrimidin-4(3h)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$84.00InquiryInquiry
1g95%$246.00InquiryInquiry
5g95%$1205.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(2-FUryl)thieno[2,3-d]pyrimidin-4(3h)-one
IUPAC Name5-(furan-2-yl)thieno[2,3-d]pyrimidin-4(3H)-one
Molecular FormulaC10H6N2O2S
Molecular Weight218.24
SMILESO=C1NC=NC2=C1C(C3=CC=CO3)=CS2
InChI KeyJTIBBSSPYDCKBN-UHFFFAOYSA-N
Synonym5-(2-furyl)-3H-thieno[3,2-e]pyrimidin-4-one;5-(2-furyl)thieno[2,3-d]pyrimidin-4(3H)-one;5-furan-2-yl-3H-thieno[3,2-e]pyrimidin-4-one;MFCD11570874;Thieno[2,3-d]pyrimidin-4(1H)-one, 5-(2-furanyl)-;5-(furan-2-yl)-3H-thieno[2,3-d]pyrimidin-4-one;5-(Furan-2-yl)thieno[2,3-d]pyrimidin-4(3h)-one
CAS No.256507-00-3

Synthetic Route by SureRoute

1. ACLUCW213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXQH124 route compound structure diagram
    ACFXQH124256506-99-7In Stock
  2. Then
  3. ACLUCW213 route product structure diagram
    ACLUCW213256507-00-3
Inquiry

2. ACLUCW213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXQH124 route compound structure diagram
    ACFXQH124256506-99-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLUCW213 route product structure diagram
    ACLUCW213256507-00-3
Inquiry

3. ACLUCW213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCGBV074 route compound structure diagram
    ACCGBV0741239460-83-3In Stock
  2. Plus
  3. ACVZGD670 route compound structure diagram
    ACVZGD67013331-23-2In Stock
  4. Then
  5. ACLUCW213 route product structure diagram
    ACLUCW213256507-00-3
Inquiry

Comments (0)